Navigation Links
Metformin Won't Aid Breast Cancer Survival in Diabetics
Date:5/14/2013

TUESDAY, May 14 (HealthDay News) -- Despite prior research suggesting that the widely used diabetes drug metformin might help cancer patients, a new study finds it does not boost survival for older breast cancer patients with diabetes.

Previous research has found that metformin was associated with an up to 30 percent reduction in new cancers in breast cancer patients without diabetes, noted study author Dr. Iliana Lega, a research fellow at Women's College Hospital in Toronto. Prior research has also tied use of the drug to slowed tumor growth.

"Metformin is a drug commonly used by diabetic patients to control the amount of glucose [sugar] in their blood," Lega explained in a hospital news release. "Although existing scientific literature suggests that the drug may prevent new cancers and death from breast cancer, our study found the drug did not significantly impact survival rates in our patients."

The study included more than 2,300 women, aged 66 and older, with diabetes who took metformin and were diagnosed with breast cancer between 1997 and 2008. The women were followed from the time of their diagnosis until their death or until early 2010.

Metformin use was not associated with any significant drop in breast cancer deaths, according to the study published online recently in the journal Diabetes Care.

"What makes our study so unique is that while the effects of metformin have been well documented, previous research has not examined the cumulative effects of the drug on patients, particularly breast cancer patients with diabetes," Lega said. "This is important given that diabetic patients may switch drugs over the course of their treatment."

She and her colleagues said further research is necessary in younger patients who have both breast cancer and diabetes.

"Understanding the effects of metformin on breast cancer patients is critical in helping address the gap in cancer outcomes in patients with and without diabetes," Lega explained. "The findings will help physicians inform treatment plans for patients with diabetes."

More information

The U.S. National Cancer Institute has more about breast cancer.

-- Robert Preidt

SOURCE: Women's College Hospital, news release, May 9, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Added benefit of saxagliptin/metformin combination is not proven
2. Metformin improves blood glucose levels and BMI in very obese children
3. Study: Metformin offers cardio benefits over sulfonylureas in diabetes
4. Metformin may lower cancer risk in people with Type 2 diabetes
5. Metformin Outperforms Common Class of Diabetes Drugs in Study
6. Value of Metformin, Insulin Combo for Type 2 Diabetes Questioned
7. Cognitive training improves executive function in breast cancer survivors
8. A Little Formula Might Help Breast-Feeding for Some Babies
9. Socializing May Ease Pain of Breast Cancer
10. Fun and friends help ease the pain of breast cancer
11. Just How Might Exercise Lower Breast Cancer Risk?
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Metformin Won't Aid Breast Cancer Survival in Diabetics
(Date:12/7/2016)... ... December 07, 2016 , ... ... now promoting to the US market its advanced highly customizable contact technology solutions. ... ODU TURNTAC®. These advanced technologies are ideal for a wide range of applications ...
(Date:12/7/2016)... ... December 07, 2016 , ... Baciocco Brothers Insurance ... residents in the Sacramento/Folsom region, is initiating a charity event to raise support ... Choice Another Chance treatment center in Sacramento works to provide area teens and ...
(Date:12/7/2016)... ... ... One of two inventors from Glen Burnie, Md., has a granddaughter who ... is why the co-inventor and I have designed a new and better way to ... of the patent-pending AV-AIR, a device that serves as an alternative to conventional methods ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... A. Kevin ... owners and families throughout the Five Boroughs, is launching a charity drive to raise ... to continue the traditions and spirit of marines and Navy FMF Corpsmen. Working closely ...
(Date:12/7/2016)... ... December 07, 2016 , ... Sharon Kleyne, host of the ... and Your Health on Voice of America, declared on her radio program in November ... the fact that when these bullies attack leaders in corporate America, they are trying ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... 2016  Palatin Technologies, Inc. ("Palatin") (NYSE MKT: ... previously disclosed underwritten public offering of units with ... sole book-running manager, Roth Capital Partners acted as ... co-manager for the offering. "This financing ... proceeds, allowing us to continue advancing bremelanotide for ...
(Date:12/7/2016)... Md. , Dec. 7, 2016  Northwest ... or the "Company"), a biotechnology company developing DCVax® ... announced that the Nasdaq Staff has not accepted ... of Listing Rules previously reported, and the Company ... withdraw the Company,s common stock from listing on ...
(Date:12/7/2016)... , December 7, 2016 ... Trial Management System (CTMS) Market, by Components (Software, ... Site), End-users (Pharmaceutical and Biotechnology Companies, Clinical Research ... Share, Size and Forecast to 2022", published by ... system (CTMS) market is expected to grow at ...
Breaking Medicine Technology: